{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05650879",
            "orgStudyIdInfo": {
                "id": "ELVN-002-001"
            },
            "organization": {
                "fullName": "Enliven Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer",
            "officialTitle": "A Phase 1a/1b Study of ELVN-002 for the Treatment of Patients With HER2 Mutant Non-Small Cell Lung Cancer",
            "acronym": "HER2",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "elvn-in-mutant-non-small-cell-lung-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-11-28",
            "studyFirstSubmitQcDate": "2022-12-06",
            "studyFirstPostDateStruct": {
                "date": "2022-12-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-06",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Enliven Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to test ELVN-002 in people with cancers that have an abnormal HER2 gene. The main question the trial aims to answer is if ELVN-002 is safe and tolerable at different doses. A second main question is to evaluate the concentration of ELVN-002 in the blood at different doses and to see how this correlates with safety and see how the concentration of drug changes over time. The third main question is to see if ELVN-002 works to shrink cancers that have HER2 genetic abnormalities, particularly non-small cell lung cancer.",
            "detailedDescription": "There are 4 parts to the trial. Part 1 is a dose escalation with ELVN-002 monotherapy for people with advanced stage solid tumors that have a HER2 mutation, amplification or high HER2 over-expression. Part 2 is an ELVN-002 monotherapy dose exploration where additional people may be enrolled at dose levels that have cleared the dose escalation in Part 1 to further evaluate the safety, tolerability, pharmacokinetics and clinical activity. Part 3 is a dose expansion of ELVN-002 monotherapy which will enroll up to 40 patients people with advanced stage HER2 mutant non-small cell lung cancer. Patients in Part 3 will be randomized 1:1 to receive one of two dose levels.\n\nPart 4 is a combination dose escalation where, based on the results of Part 1 and 2, a combination of ELVN-002 and either fam-trastuzumab deruxtecan-nxki (in HER2 mutant non-small cell lung cancer) or trastuzumab emtansine (in HER2 positive breast cancer) will be evaluated for safety and tolerability."
        },
        "conditionsModule": {
            "conditions": [
                "HER2 Mutant Non-small Cell Lung Cancer",
                "HER2-positive Metastatic Breast Cancer",
                "HER2 Gene Mutation",
                "HER2 Amplification"
            ],
            "keywords": [
                "HER2 genetic alterations",
                "HER2 mutation",
                "ELVN-002",
                "Non-small cell lung cancer",
                "HER-2 positive metastatic breast cancer",
                "Enhertu",
                "trastuzumab emtansine",
                "fam-trastuzumab deruxtecan-nxki",
                "Kadcyla"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "Phase 1 will be a dose escalation monotherapy according to the Bayesian Optimal Interval Design model Phase 1b will be a dose expansion: up to 40 patients randomized between 2 dose levels",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 198,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 1a Monotherapy Dose Escalation",
                    "type": "EXPERIMENTAL",
                    "description": "ELVN-002 will be administered either once or twice daily. Each cohort of patients will receive a higher dose. ELVN-002 is an oral capsule. Duration of treatment will be until disease progression or patient discontinues ELVN-002 for another reason.",
                    "interventionNames": [
                        "Drug: ELVN-002"
                    ]
                },
                {
                    "label": "Phase 1a Monotherapy Dose Exploration",
                    "type": "EXPERIMENTAL",
                    "description": "ELVN-002 will be administered either once or twice daily. A maximum of 80 patients will enroll in this arm. A maximum of 10 patients may be enrolled at a single dose or tumor type. ELVN-002 is an oral capsule. Duration of treatment will be until disease progression or patient discontinues ELVN-002 for another reason.",
                    "interventionNames": [
                        "Drug: ELVN-002"
                    ]
                },
                {
                    "label": "Phase 1b Monotherapy Dose Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "ELVN-002 will be administered either once or twice daily. A maximum of 40 patients will enroll in this arm. Patients will be randomized 1:1 to one of two dose levels.\n\nELVN-002 is an oral capsule. Duration of treatment will be until disease progression or patient discontinues ELVN-002 for another reason.",
                    "interventionNames": [
                        "Drug: ELVN-002"
                    ]
                },
                {
                    "label": "Phase 1a Combination Dose Escalation with T-DXd",
                    "type": "EXPERIMENTAL",
                    "description": "ELVN-002 will be administered either once or twice daily starting on Day 1. ELVN-002 is an oral capsule. Each cohort will receive a higher dose of ELVN-002. All patients in all cohorts will initiate with 5.4mg/kg of intravenous T-DXd once every 3 weeks starting on day 22 of the study. Duration of treatment will be until disease progression or patient discontinues ELVN-002 for another reason.",
                    "interventionNames": [
                        "Drug: ELVN-002",
                        "Drug: Fam-Trastuzumab Deruxtecan-Nxki"
                    ]
                },
                {
                    "label": "Phase 1a Combination Dose Escalation with T-DM1",
                    "type": "EXPERIMENTAL",
                    "description": "ELVN-002 will be administered either once or twice daily starting on Day 1. ELVN-002 is an oral capsule. Each cohort will receive a higher dose of ELVN-002. All patients in all cohorts will initiate with 3.6 mg/kg of intravenous T-DM1 once every 3 weeks starting on day 22 of the study. Duration of treatment will be until disease progression or patient discontinues ELVN-002 for another reason.",
                    "interventionNames": [
                        "Drug: ELVN-002",
                        "Drug: Trastuzumab emtansine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "ELVN-002",
                    "description": "capsule",
                    "armGroupLabels": [
                        "Phase 1a Combination Dose Escalation with T-DM1",
                        "Phase 1a Combination Dose Escalation with T-DXd",
                        "Phase 1a Monotherapy Dose Escalation",
                        "Phase 1a Monotherapy Dose Exploration",
                        "Phase 1b Monotherapy Dose Expansion"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fam-Trastuzumab Deruxtecan-Nxki",
                    "description": "intravenous",
                    "armGroupLabels": [
                        "Phase 1a Combination Dose Escalation with T-DXd"
                    ],
                    "otherNames": [
                        "Enhertu",
                        "T-DXd"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Trastuzumab emtansine",
                    "description": "intravenous",
                    "armGroupLabels": [
                        "Phase 1a Combination Dose Escalation with T-DM1"
                    ],
                    "otherNames": [
                        "Kadcyla",
                        "T-DM1"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of dose limiting toxicities in Phase 1a monotherapy",
                    "timeFrame": "21 days"
                },
                {
                    "measure": "Incidence of adverse events in Phase 1a monotherapy",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of laboratory abnormalities in Phase 1a monotherapy",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of ECG abnormalities in Phase 1a monotherapy",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of dose limiting toxicities in Phase 1a combination with fam-trastuzumab deruxtecan (T-DXd)",
                    "timeFrame": "42 days"
                },
                {
                    "measure": "Incidence of adverse events in Phase 1a combination with T-DXd",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of laboratory abnormalities in Phase 1a combination with T-DXd",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of ECG abnormalities in Phase 1a combination with T-DXd",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of dose limiting toxicities in Phase 1a combination with trastuzumab emantasine (T-DM1)",
                    "timeFrame": "42 days"
                },
                {
                    "measure": "Incidence of adverse events in Phase 1a combination with T-DM1",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of laboratory abnormalities in Phase 1a combination with T-DM1",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of ECG abnormalities in Phase 1a combination with T-DM1",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Incidence of adverse events in Phase 1b monotherapy",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of laboratory abnormalities in Phase 1b monotherapy",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "incidence of ECG abnormalities in Phase 1b monotherapy",
                    "timeFrame": "24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Objective Response rate in Phase 1a monotherapy",
                    "description": "For patients with measurable disease at baseline, confirmed response per RECIST 1.1",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Objective response rate in Phase 1b monotherapy",
                    "description": "Confirmed response per RECIST 1.1",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Duration of response in Phase 1b monotherapy",
                    "description": "The time from the first response to progression or death per RECIST 1.1",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Brain metastases response in Phase 1b monotherapy",
                    "description": "for patients with measurable brain metastases at baseline, the percent of patients who have a confirmed response per RECIST 1.1",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "PK parameter of area under the curve of ELVN-002 in Phase 1a monotherapy",
                    "description": "the concentration of ELVN-002 measured in the blood over 24 hours at steady state",
                    "timeFrame": "21 days"
                },
                {
                    "measure": "PK parameter of maximum concentration of ELVN-002 in Phase 1a monotherapy",
                    "description": "the maximum concentration of ELVN-002 measured in the blood at any time point at steady state",
                    "timeFrame": "21 days"
                },
                {
                    "measure": "PK parameter of terminal half life of ELVN-002 in Phase 1a monotherapy",
                    "description": "the half life of ELVN-002 calculated from the concentration of ELVN-002 in blood",
                    "timeFrame": "21 days"
                },
                {
                    "measure": "PK parameter of area under the curve of ELVN-002 in Phase 1b monotherapy",
                    "description": "the concentration of ELVN-002 measured in the blood over 24 hours at steady state",
                    "timeFrame": "21 days"
                },
                {
                    "measure": "PK parameter of maximum concentration of ELVN-002 in Phase 1b monotherapy",
                    "description": "the maximum concentration of ELVN-002 measured in the blood at any time point at steady state",
                    "timeFrame": "21 days"
                },
                {
                    "measure": "PK parameter of terminal half life of ELVN-002 in Phase 1b monotherapy",
                    "description": "the half life of ELVN-002 calculated from the concentration of ELVN-002 in blood",
                    "timeFrame": "21 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nPhase 1a Monotherapy Dose Escalation and Exploration:\n\n* Pathologically documented advanced stage solid tumor\n* Progressed following all standard treatment or not appropriate for standard treatment\n* HER2 mutation, HER2 amplification or HER2 positive based on local testing\n\nPhase 1b Monotherapy\n\n* Pathologically documented unresectable and/or metastatic non-squamous NSCLC\n* HER2 mutation identified by tissue (fresh or archival) or ctDNA. Local testing for up to 20 patients the remainder centrally confirmed.\n* Measurable disease\n* No known epidermal growth factor receptor (EGFR), ROS1, anaplastic lymphoma kinase (ALK), or BRAF V600E mutation\n* Progressed after receiving at least 1 prior systemic therapy including a platinum-based chemotherapy with or without immunotherapy, or not appropriate for standard treatment.\n* No prior HER2 tyrosine kinase inhibitor. Prior HER2 directed antibodies or anti-body drug conjugates are allowed\n* No limit on prior number of therapies\n\nPhase 1a Combination with T-DXd\n\n* Pathologically documented advanced stage NSCLC\n* Progressed after receiving at least 1 prior systemic therapy.\n* HER2 mutation based on local/historical testing of tissue or circulating tumor DNA\n* No known EGFR, ROS1, ALK, or BRAF V600E mutation\n* No prior T-DXd\n* No clinically severe pulmonary compromise\n* No limit on prior number of therapies\n\nPhase 1a Combination Breast Cancer\n\n* Documented HER2 positive (Immunohistochemical \\[IHC\\] 3+ or IHC2+/in situ hybridization (ISH+) breast cancer\n* Must have previously received trastuzumab, a taxane, and T-DXd (if available and appropriate) in the metastatic setting.\n* No limit on prior number of therapies\n* No prior T-DM1\n\nAll Phases\n\n* Eastern Cooperative Oncology Group performance status of 0-1\n* Left ventricular ejection fraction \u2265 50%\n* Platelet count \u2265 100 x 109/L\n* Hemoglobin \u2265 8.5 g/dL\n* Absolute neutrophil count \u22651.0 x 109/L\n* Total bilirubin \\< 1.5 times upper limit of normal range (ULN), except for patients with Gilbert's syndrome\n* Aspartate aminotransferase (AST), alanine aminotransferase (ALT) \\< 3 times ULN. In the setting of liver metastases \\< 5 times ULN.\n* Creatinine clearance \u2265 60 mL/minute\n\nExclusion Criteria All Phases:\n\n* Severe cardiac arrhythmias, requiring treatment, symptomatic congestive heart failure, myocardial infarction within 28 days prior to first dose, or unstable angina.\n* Another active malignancy within 2 years except basal cell skin cancer and carcinoma in situ treated curatively\n* Active or chronic liver disease\n* Active infection requiring systemic therapy within 14 days before the first dose\n* Brain lesion requiring immediate local therapy\n* Leptomeningeal disease\n* Uncontrolled seizures\n* Corrected QT interval (QTc) of \\>470 milliseconds (ms) females or \\>450 ms for males by Fridericia (QTcF)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Helen L Collins, MD",
                    "role": "CONTACT",
                    "phone": "707 799-3272",
                    "email": "helen.collins@enliventherapeutics.com"
                },
                {
                    "name": "Sabine Tricon",
                    "role": "CONTACT",
                    "email": "sabine.tricon@enliventherapeutics.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado - Anschutz Medical Campus - PPDS",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tejas Patil, MD",
                            "role": "CONTACT",
                            "phone": "720-848-0170"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Advent Health Orlando",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32804",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mark Socinski, MD",
                            "role": "CONTACT",
                            "phone": "407-303-2024"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "BRCR Medical Center Inc",
                    "status": "RECRUITING",
                    "city": "Plantation",
                    "state": "Florida",
                    "zip": "33322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Harsad Amin, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.13421,
                        "lon": -80.23184
                    }
                },
                {
                    "facility": "Dana Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Julia Rotow, MD",
                            "role": "CONTACT",
                            "phone": "617-632-4764"
                        },
                        {
                            "name": "Rebecca Rivenburgh",
                            "role": "CONTACT",
                            "phone": "(617) 632-4764"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "NEXT/Virginia Cancer Specialists",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexander Spira, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Macquarie University Hospital",
                    "status": "RECRUITING",
                    "city": "Westmead",
                    "state": "New South Wales",
                    "zip": "2145",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Dhanusha Sabanathan, BSc, MBBS",
                            "role": "CONTACT",
                            "phone": "+61298458238"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.80383,
                        "lon": 150.98768
                    }
                },
                {
                    "facility": "Linear Clinical Research Limited",
                    "status": "RECRUITING",
                    "city": "Nedlands",
                    "state": "Western Australia",
                    "zip": "6009",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Samantha Bowyer, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": -31.98184,
                        "lon": 115.8073
                    }
                },
                {
                    "facility": "Blacktown Hospital",
                    "status": "RECRUITING",
                    "city": "Darlinghurst",
                    "zip": "2010",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Adnan Nagrial, BS, MB, MBBS",
                            "role": "CONTACT",
                            "phone": "+61292958100"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.87939,
                        "lon": 151.21925
                    }
                },
                {
                    "facility": "H\u00f4pital de la Timone Centre d'essais en canc\u00e9rologie de Marseille (CEPCM-CLIPP)",
                    "status": "RECRUITING",
                    "city": "Marseille",
                    "state": "Bouches-du-Rh\u00f4ne",
                    "zip": "13005",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Laurent Greillier, MD",
                            "role": "CONTACT",
                            "phone": "+33491965901"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "H\u00f4pital Pontchaillou",
                    "status": "RECRUITING",
                    "city": "Rennes",
                    "state": "Brittany",
                    "zip": "35033",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Herv\u00e9 Herv\u00e9, MD",
                            "role": "CONTACT",
                            "phone": "+33299283738"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.11198,
                        "lon": -1.67429
                    }
                },
                {
                    "facility": "Centre Francois Baclesse",
                    "status": "RECRUITING",
                    "city": "Caen",
                    "state": "Calvados",
                    "zip": "14076",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Hubert Curcio, MD",
                            "role": "CONTACT",
                            "phone": "+33231455289"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.18585,
                        "lon": -0.35912
                    }
                },
                {
                    "facility": "Centre L\u00e9on Berard",
                    "status": "RECRUITING",
                    "city": "Lyon",
                    "state": "Cedex 8",
                    "zip": "69373",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Aurelie Swalduz, MD",
                            "role": "CONTACT",
                            "phone": "+33426556833"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "Centre Georges Fran\u00e7ois Leclerc",
                    "status": "RECRUITING",
                    "city": "Dijon",
                    "state": "C\u00f4te-d'Or",
                    "zip": "21079",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Fran\u00e7ois Ghiringhelli, MDPhD",
                            "role": "CONTACT",
                            "phone": "+33380737524"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.31667,
                        "lon": 5.01667
                    }
                },
                {
                    "facility": "EDOG - Institut Bergonie - PPDS",
                    "status": "RECRUITING",
                    "city": "Bordeaux",
                    "state": "Gironde",
                    "zip": "33000",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Laura Leroy, MDPhD",
                            "role": "CONTACT",
                            "phone": "+33547306088"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.84044,
                        "lon": -0.5805
                    }
                },
                {
                    "facility": "Institut Gustave Roussy (IGR)",
                    "status": "RECRUITING",
                    "city": "Villejuif Cedex",
                    "zip": "94805",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Benjamin Besse, MD",
                            "role": "CONTACT",
                            "phone": "+33142114322"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.7939,
                        "lon": 2.35992
                    }
                },
                {
                    "facility": "Fondazione IRCCS San Gerardo dei Tintori",
                    "status": "RECRUITING",
                    "city": "Monza",
                    "state": "Lombardia",
                    "zip": "20900",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Marina Cazzaniga, MD",
                            "role": "CONTACT",
                            "phone": "+390392339037"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.58005,
                        "lon": 9.27246
                    }
                },
                {
                    "facility": "Azienda Ospedaliero Universitaria delle Marche",
                    "status": "RECRUITING",
                    "city": "Ancona",
                    "state": "Marche",
                    "zip": "60126",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Rossana Berardi, MD",
                            "role": "CONTACT",
                            "phone": "+390715965715"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.5942,
                        "lon": 13.50337
                    }
                },
                {
                    "facility": "Fondazione del Piemonte per l'Oncologia (IRCCS)",
                    "status": "RECRUITING",
                    "city": "Candiolo",
                    "state": "Piemonte",
                    "zip": "10060",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Vanesa Gregorc, MD",
                            "role": "CONTACT",
                            "phone": "+390119933915"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.95858,
                        "lon": 7.59812
                    }
                },
                {
                    "facility": "SOC Oncologia Medica e dei Tumori lmmunocorrelati, Centro Di Riferimento Oncologico Di Aviano (CRO) IRCCS",
                    "status": "RECRUITING",
                    "city": "Aviano",
                    "state": "Pordenone",
                    "zip": "33081",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Alessandra Bearz, MD",
                            "role": "CONTACT",
                            "phone": "+390434659294"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.07056,
                        "lon": 12.59472
                    }
                },
                {
                    "facility": "Fondazione Policlinico Universitario A. Gemelli",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "zip": "00168",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Gennaro Daniele, MD",
                            "role": "CONTACT",
                            "phone": "+390630158802"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Unit\u00e0 Operativa Oncologia medica ed Ematologia",
                    "status": "RECRUITING",
                    "city": "Rozzano",
                    "zip": "20089",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Armando Santoro, MD",
                            "role": "CONTACT",
                            "phone": "+390282244080"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.38193,
                        "lon": 9.1559
                    }
                },
                {
                    "facility": "The Catholic University of Korea, St. Vincent's Hospital",
                    "status": "RECRUITING",
                    "city": "Suwon",
                    "state": "Gyeonggido",
                    "zip": "16247",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Byoung Yong Shim, MD",
                            "role": "CONTACT",
                            "phone": "+82312497120"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.29111,
                        "lon": 127.00889
                    }
                },
                {
                    "facility": "Gachon University Gil Medical Center",
                    "status": "RECRUITING",
                    "city": "Incheon",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Young Saing Kim, MDPhD",
                            "role": "CONTACT",
                            "phone": "+82324603213"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.45646,
                        "lon": 126.70515
                    }
                },
                {
                    "facility": "Severence Hospital, Yonsei University",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Byoung Chul Cho, MD",
                            "role": "CONTACT",
                            "phone": "+82222288216"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Myung-Ju Ahn, MDPhD",
                            "role": "CONTACT",
                            "phone": "+82234103438"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "3080",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Tae Min Kim, MD, PhD",
                            "role": "CONTACT",
                            "phone": "+82220723559"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Korea University Anam Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Sang Won Shin, MD",
                            "role": "CONTACT",
                            "phone": "+8229205350"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "START Barcelona Hospital HM Nou Delfos",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08023",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Tatiana Hernandez Guerrero",
                            "role": "CONTACT",
                            "phone": "+34915504800"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Universitari Vall d'Hebr\u00f3n",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Guzman Alonso Casal, MD",
                            "role": "CONTACT",
                            "phone": "+34932381661"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "lnstitut Catala d'Oncologia (ICO) L'Hospitalet, Servicio de Oncologia Medica",
                    "status": "RECRUITING",
                    "city": "L'Hospitalet de Llobregat",
                    "zip": "08908",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Mar\u00eda Jov\u00e9 Casulleras,, MD",
                            "role": "CONTACT",
                            "phone": "+34932607744"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.35967,
                        "lon": 2.10028
                    }
                },
                {
                    "facility": "Hospital Universitari Arnau de Vilanova",
                    "status": "RECRUITING",
                    "city": "Lleida",
                    "zip": "25198",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Seraf\u00edn Morales, MD",
                            "role": "CONTACT",
                            "phone": "+34973705342"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.61674,
                        "lon": 0.62218
                    }
                },
                {
                    "facility": "Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Victor Moreno Garcia, MD PhD",
                            "role": "CONTACT",
                            "phone": "+34915504800"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario 12 de Octubre",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28041",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Jon Zugazagoitia, MD",
                            "role": "CONTACT",
                            "phone": "+34914692313"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Virgen Macarena",
                    "status": "RECRUITING",
                    "city": "Sevilla",
                    "zip": "41009",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "David Vicente Baz, MD",
                            "role": "CONTACT",
                            "phone": "+34671590011"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46009",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Ignacio Gil Bazo, MD",
                            "role": "CONTACT",
                            "phone": "+34961114229"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Hospital Universitari i Polit\u00e8cnic La Fe",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46026",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Oscar Jose Juan Vidal, MD, PhD",
                            "role": "CONTACT",
                            "phone": "+34961245867"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Taichung Veterans General Hospital",
                    "status": "RECRUITING",
                    "city": "Taichung City",
                    "zip": "40705",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Tsung-Ying Yang, MD",
                            "role": "CONTACT",
                            "phone": "+886423592525",
                            "phoneExt": "3219"
                        }
                    ],
                    "geoPoint": {
                        "lat": 24.1469,
                        "lon": 120.6839
                    }
                },
                {
                    "facility": "National Chen Kung University Hospital",
                    "status": "RECRUITING",
                    "city": "Tainan",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Chun-Hui Lee, MD",
                            "role": "CONTACT",
                            "phone": "+88662353535"
                        }
                    ],
                    "geoPoint": {
                        "lat": 22.99083,
                        "lon": 120.21333
                    }
                },
                {
                    "facility": "National Taiwan University Hospital",
                    "status": "RECRUITING",
                    "city": "Taipei City",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Chia-Chi Lin, MDPhD",
                            "role": "CONTACT",
                            "phone": "+886223123456"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000068878",
                    "term": "Trastuzumab"
                },
                {
                    "id": "D000080044",
                    "term": "Ado-Trastuzumab Emtansine"
                },
                {
                    "id": "D000008453",
                    "term": "Maytansine"
                },
                {
                    "id": "C000614160",
                    "term": "Trastuzumab deruxtecan"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000922",
                    "term": "Immunotoxins"
                },
                {
                    "id": "D000018796",
                    "term": "Immunoconjugates"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M325",
                    "name": "Trastuzumab",
                    "asFound": "Follow-up",
                    "relevance": "HIGH"
                },
                {
                    "id": "M233243",
                    "name": "Trastuzumab deruxtecan",
                    "asFound": "Tilt",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2102",
                    "name": "Ado-Trastuzumab Emtansine",
                    "asFound": "Supporting",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3595",
                    "name": "Adenosine",
                    "relevance": "LOW"
                },
                {
                    "id": "M11436",
                    "name": "Maytansine",
                    "asFound": "Opioid Use",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4241",
                    "name": "Immunotoxins",
                    "relevance": "LOW"
                },
                {
                    "id": "M20855",
                    "name": "Immunoconjugates",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                }
            ]
        }
    },
    "hasResults": false
}